Zhewitra-20 is a medication commonly used to treat erectile dysfunction (ED) in men. It belongs to the class of drugs called phosphodiesterase type 5 (PDE5) inhibitors, which aim to improve blood flow to the penis by relaxing the blood vessels.
The active half-life of Zhewitra-20 is between 5 and 7 hours, meaning that it is relatively fast-acting and should be taken shortly before sexual activity. It is important to follow the prescribed dosing instructions carefully, as taking more than the recommended amount may increase the risk of side effects.
Zhewitra-20 is available in a dosage of 20 mg per day for men. It typically comes in the form of a blister pack of ten pills, each containing 20 mg of the active substance Vardenafil. The medication is manufactured by the pharmaceutical company Sunrise Remedies, which is based in India.
One of the benefits of using Zhewitra-20 is that it does not typically cause acne or water retention. However, hormonal changes caused by the medication may potentially cause HBR or gynecomastia in some users. Zhewitra-20 is generally not associated with hepatotoxicity or aromatization.
Overall, Zhewitra-20 is an effective form of ED treatment that can help men achieve and maintain an erection. It is generally well-tolerated, but like any medication, it may cause side effects in some individuals. It is important to talk to a healthcare provider if any concerns or side effects arise.
Chemical name: 1-(((3-(3,4-dihydro-5-methyl)-4-oxo-7-propylimidazo(5,1-f)-as-triazin-2-yl)-4-ethoxyphenyl)sulfonyl)-4-ethylpiperazine
Anabolic activity index: not a steroid
Androgenic activity index: not a steroid